Back to Search
Start Over
Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction
- Source :
- American Journal of Respiratory and Critical Care Medicine. 195:881-888
- Publication Year :
- 2017
- Publisher :
- American Thoracic Society, 2017.
-
Abstract
- Inhaled corticosteroids have been shown to decrease exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Their effects in patients with milder airflow obstruction remain unclear.This was an analysis of exacerbations in the SUMMIT (Study to Understand Mortality and Morbidity) study.In a double-blind, randomized controlled trial, once-daily inhaled placebo, fluticasone furoate (FF; 100 μg), vilanterol (VI; 25 μg), or the combination of FF/VI was administered. The primary outcome was all-cause mortality. Exacerbations of COPD were an additional predefined endpoint. A total of 1,368 centers in 43 countries and 16,485 patients with moderate COPD and heightened cardiovascular risk were included in the study.Compared with placebo, FF/VI reduced the rate of moderate and/or severe exacerbations by 29% (95% confidence interval [CI], 22-35; P 0.001) and the rate of hospitalized exacerbations by 27% (95% CI, 13-39; P 0.001). These relative effects were similar regardless of whether subjects had a history of exacerbation in the year before the study or an FEVPatients with moderate chronic airflow obstruction experienced a reduction in exacerbations with FF/VI compared with placebo, irrespective of a history of exacerbations or baseline FEV
- Subjects :
- Male
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Chlorobenzenes
Critical Care and Intensive Care Medicine
Placebo
Fluticasone propionate
law.invention
Pulmonary Disease, Chronic Obstructive
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Double-Blind Method
Randomized controlled trial
Adrenal Cortex Hormones
law
Forced Expiratory Volume
Internal medicine
Administration, Inhalation
medicine
Humans
Prospective Studies
030212 general & internal medicine
Prospective cohort study
Benzyl Alcohols
Aged
COPD
business.industry
Airway obstruction
medicine.disease
Confidence interval
Bronchodilator Agents
Airway Obstruction
Androstadienes
Treatment Outcome
030228 respiratory system
chemistry
Anesthesia
Female
Vilanterol
business
medicine.drug
Subjects
Details
- ISSN :
- 15354970 and 1073449X
- Volume :
- 195
- Database :
- OpenAIRE
- Journal :
- American Journal of Respiratory and Critical Care Medicine
- Accession number :
- edsair.doi.dedup.....44120e97c974d36110f6a5bf9ba75144
- Full Text :
- https://doi.org/10.1164/rccm.201607-1421oc